Thoracic Cancer

Article	Citations
Issue Information	335
Issue Information	54
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1	51
Issue Information	51
Issue Information	50
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway	41
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction	37
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma	33
Issue Information	32
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report	30
Pathological characteristics of lung tumors in Sri Lanka 2017–2021	29
Sortilin‐1, Targeted by miR‐146a, Regulates the Behavior of Non‐Small Cell Lung Cancer	29
PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC	27
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study	27
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China	27
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab	26
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomize	26
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035	25
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation	25
Correction to “The Prevalence, Distribution, and Clinicopathological Features of Seven Lung Cancer Actionable Driver Mutations in Taiwan”	25
Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer	24
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases	24
Danshensu Ethyl Ester Induces Ferroptosis Through Targeted Inhibition of SLC7A11 Transport Function in NSCLC	24
Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema	24
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells	23

Issue Information	23
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control	23
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer	22
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer	22
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report	22
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor	22
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma	22
The Relationship Between Pulmonary Spiculation and Central Fibrosis, Along With Other Clinicopathological Features, in Invasive Lung Adenocarcinoma and Its Prognostic Significance	21
Cervical Anastomotic Leakage After Minimally Invasive McKeown Esophagectomy in the SAFER Surgical	20
Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors	20
Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS	20
Comparison of Early Functional Recovery Following Triportal Robot‐Assisted and Uniportal Video‐Assisted Segmentectomy in Patients With Early‐Stage Non‐Small Cell Lung Cancer: A Propensity Score‐Matche	20
	19
	19
Issue Information	19
Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study	18
Intrinsic resistance to ROS1 inhibition in a patient with CD74‐ROS1 mediated by AXL overexpression	18
Implication of IZUMO2 in the cell‐in‐cell phenomenon: A potential therapeutic target for triple‐negative breast cancer	18
Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study	18
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences	18
Issue Information	17
Issue Information	17
KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway	17
	17
First‐Line Immune‐Combination Therapy for Driver Gene‐Negative NSCLC With Brain Metastases: Real‐World Outcomes	17
Circ_0004140 promotes lung adenocarcinoma progression by upregulating NOVA2 via sponging miR‐330‐5p	16
Response Letter to “Management of Chylothorax Following Thoracic Surgery” by Busetto et al.	16
Clinicopathological analysis of a superior sulcus tumor treated by salvage surgery after concurrent definitive chemoradiotherapy followed by durvalumab: A case report	16
The regularity of anatomical variations of dominant pulmonary segments in the right upper lobe	16
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib	16
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non‐small cell lung cancer harboring BRAF V600E mutation: A	16
Revisiting ALK (D5F3) immunohistochemistry: Insights into focal staining and neuroendocrine differentiation	16
S‐ and R‐Carvedilol Prevent Benzo(a)pyrene‐Induced Lung Carcinogenesis	16
Safety and feasibility of a novel chest tube placement in uniportal video‐assisted thoracoscopic surgery for non‐small cell lung cancer	16
Potential activity of adiponectin‐expressing regulatory T cells against triple‐negative breast cancer cells through the cell‐in‐cell phenomenon	16
There Is More Than Meets the Eye With Ground Glass Nodules: Is It Too Early to Adopt Sublobar Resection as Standard of Care for Early Stage Lung Adenocarcinoma?	16
PICC Maintenance Challenges Among Esophageal Cancer Patients: A Qualitative Study	15
Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: A single institution experience	15
Correction to “Stability and safety of transbronchial dye mixture for preoperative localization in a porcine model”	15
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma	15
Non‐small cell lung carcinoma with focal coexpression of thyroid transcription factor‐1 and Δ Np63/p40: A case report	15
Prevalence and Correlates of Distress Detected by the Distress Thermometer and Problem List in Lung Cancer Patients: A Cross‐Sectional Study	15
Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non‐Small Cell Lung Cancer: A Single‐Institution Retrospective Study	15
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy	15
Corrigendum	15
An Innovative Management in the Diagnosis of Mediastinal Masses	15
Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study	15
The association of nutritional and inflammatory biomarkers with overall survival in patients with non‐small‐cell lung cancer treated with immune checkpoint inhibitors	15
Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR‐6838‐5p	15
SLC34A2 promotes cell proliferation by activating STX17‐mediated autophagy in esophageal squamous cell carcinoma	15

Predicting visceral pleural invasion in lung adenocarcinoma presenting as part‐solid density utilizing a nomogram model combined with radiomics and clinical features	14
Issue Information	14
Clinical Significance of Bone Metastases in Pleural Mesothelioma	14
Evaluating the Role of Advanced Age and Risk Factors in Postoperative Outcomes Following Major Lung Cancer Resection	14
Everolimus in combination with octreotide LAR in thymic atypical carcinoid	14
	14
Serum cross‐linked N‐telopeptide of type I collagen as a potential diagnostic marker for bone metastasis in lung cancer: An updated meta‐analysis	14
Issue Information	14
Issue Information	14
	13
Issue Information	13
Clinical Outcomes of Later‐Generation EGFR ‐ TKIs for Uncommon EGFR	13
A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect	13
A novel evaluation model of image registration for cone‐beam computed tomography guided lung cancer radiotherapy	13
“Separated” precise subsegmentectomy: Single‐port thoracoscopic noncombined subsegmentectomy in one lung lobe	13
Real‐World Evidence That Non‐Smokers With High PD‐L1 Non‐Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors	13
Segmentectomy Versus Lobectomy in Early Non‐Small Cell Lung Cancer: A Population‐Based Analysis in Northern Italy	13
Issue Information	13
Issue Information	13
Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure	13
	13
Platinum‐combination chemotherapy with or without immune‐checkpoint inhibitor in patients with postoperative recurrent non‐small cell lung cancer previously treated with adjuvant platinum‐doublet chem	13
Nivolumab as maintenance therapy following platinum‐based chemotherapy in EGFR‐mutant lung cancer patients after tyrosine kinase inhibitor failure: A single‐arm, open‐label, phase 2	13
	13
Issue Information	13
Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis	13
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer	13
A case of concurrent follicular lymphoma and lung cancer requiring differentiation from lymph node metastasis	13
Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion–insertion R) in an advanced non‐small cell lung cancer patient	13
Ventilation challenge in rigid bronchoscopy: Laser tube as an alternative management in patients with lung cancer and central airway obstruction	12
Correction to “Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy	12
Association of Wearable Activity Monitors and Digital Drainage Device With Daily Ambulation and Length of Stay Among Pulmonary Resection Patients: A Prospective, Randomized Controlled Study	12
Issue Information	12
Kirsten Rat Sarcoma Viral Oncogene Homolog ( KRAS ) Mutation Testing Trends, Prevalence, and Outcomes in Metastatic, Non‐Squamous Non‐Small Cell Lung	12
Issue Information	12
Radiological and pathological analysis of the galaxy sign in patients with pulmonary mucosa‐associated lymphoid tissue (MALT) lymphoma	12
Optimizing Surgery Strategies in Stage IB Lung Squamous Cell Carcinoma: Insights from Interpretable Machine Learning	12
Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study	12
Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis	12
Examination of the effectiveness of local therapy for oligo‐recurrence of EGFR‐mutated NSCLC	12
A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer	12
Mucoepidermoid carcinoma cured by a combination of high‐frequency snare and photodynamic therapy: A case report	12
Mutations and expressions of breast cancer 1/2 in lung cancer	12
Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients	12
Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer	11
	11
Multiple micromeningiomas coexist with primary lung adenocarcinoma: A case report	11
Nondiagnostic, radial‐probe endobronchial ultrasound‐guided biopsy for peripheral lung lesions: The added value of radiomics from ultrasound imaging for predicting malignancy	11
Circular RNA, circular RARS, promotes aerobic glycolysis of non‐small‐cell lung cancer by binding with LDHA	11
Factors affecting long‐term survival of non‐small‐cell lung cancer patients with concomitant type 2 diabetes mellitus	11
	11
Issue Information	11
Pleural‐Based GLI1 ‐Altered Mesenchymal Tumor With ACTB‐GLI1 Fusion: A Rare Pulmonary Entity Mimicking Syn	11
Real‐World Analysis of Treatment Patterns in Limited‐Stage Small Cell Lung Cancer: Implications for Clinical Practice	11
Three‐dimensional lung reconstructions for the localization of lung nodules to be resected during surgery	11
Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer	11
Issue Information	11
Impact of sarcopenia on the prognosis of patients with advanced non‐small cell lung cancer treated with antiangiogenic therapy: A propensity score matching analysis	11
Burden of Breast Cancer and Its Attributable Risk Factors in the Belt and Road Initiative Countries, 1990–2021	11
CORRECTION	11
Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma	11
The utility of bispectral index monitoring in flexible bronchoscopy: A single‐center, retrospective observational study	10
Quantitative analysis of imaging characteristics in lung adenocarcinoma in situ using artificial intelligence	10
	10
The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma	10
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma	10
Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma	10
Neoadjuvant Glucocorticoids Facilitate Resection in Advanced B‐Type Thymomas: A Propensity‐Matched Analysis of Surgical and Survival Outcomes	10
Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non‐Small Cell Lung Cancer	10
Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens	10
Chylothorax After Thoracic Surgery: How We Manage It	10
Tumor‐derived exosomal miR‐148b‐3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion	10
Update on therapeutic strategy for esophageal anastomotic leak: A systematic literature review	10
Epithelial‐Mesenchymal Plasticity in the D‐Meso‐Sonobe Mesothelioma Cell Line: A Putative Model of Epithelial–Mesenchymal Transition in Mesothelioma	10
Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non‐small cell lung cancer	10
METTL3‐mediated the m6A modification of SF3B4 facilitates the development of non‐small cell lung cancer by enhancing LSM4 expression	10
Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer	10
Treatment and mortality risk of older adults with non‐small cell cancer in Taiwan: A population‐based cohort study	10
Bronchiolar adenoma/ciliated muconodular papillary tumor mixed with adenocarcinoma in situ in the same tumor	10
The Impact of Adjuvant Radiotherapy Combined With Targeted or Immunotherapy on the Heart in Breast Cancer	10

Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR ‐136‐5p/ Y	9
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR	9
	9
Dual Suturing Technique Without Tying for Closure of the Bronchial Stump in Robotic Surgery	9
Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy	9
GIMAP7 inhibits epithelial‐mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway	9
The predictive value of the preoperative systemic immune‐inflammation index in the occurrence of postoperative pneumonia in non‐small cell lung cancer: A retrospective study base	9
	9
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report	9
USP22 promotes gefitinib resistance and inhibits ferroptosis in non‐small cell lung cancer by deubiquitination of MDM2	9
	9
Lepidic growth component as a favorable prognostic factor in non–small cell lung cancer of ≤3 cm	9
	9
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer	9
Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease	9
Circ‐EIF3I facilitates proliferation, migration, and invasion of lung cancer via regulating the activity of Wnt/β‐catenin pathway through the miR‐1253/NOVA2 axis	9
Impact of Antibiotic on Efficacy and Adverse Reactions of Chemoimmunotherapy in Non‐small Cell Lung Cancer Patients: A Retrospective Cohort Study	9
Significance of Platinum‐Based Chemotherapy With Programmed Death‐1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective Study	9
Identification of the intersegmental plane via electromagnetic navigation for anatomical segmentectomy	9
Prognostic Impact of Tumor Solid Components in Stereotactic Body Radiotherapy for Clinical Stage Tis–1N0M0 Lung Cancer	9
Bronchiolar adenoma/ciliated muconodular papillary tumor complicated by lymphoid interstitial pneumonia in a patient with Sjögren's disease: A case report and systematic review	9
Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma	9
	9
Factors affecting accuracy of clinical staging in resectable non‐small cell lung cancer in a real‐world study	9
Circulation of rare events in the liquid biopsy for early detection of lung mass lesions	9
Chinese expert consensus on cone‐beam CT‐guided diagnosis, localization and treatment for pulmonary nodules	9
Issue Information	9
Division of the intersegmental demarcation using the “modified hand‐tearing method” is safe and feasible in thoracoscopic anatomical segmentectomy	9
Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR‐mutated lung adenocarcinoma	9
Solitary extramedullary plasmacytoma of the left main bronchus: A case report and literature review	9
	8
	8
The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio ( NLR ) for Response to Neoadjuvant Immunochemotherapy in Resectable	8
Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations	8
Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data	8
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive‐stage small cell lung cancer (ES‐SCLC): Study protocol	8
Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim	8
CT ‐Guided Cryoablation Achieves Significantly Higher Local Tumor Control in Sub‐Solid Lung Tumors Compared With Solid Tumors: A Retrospective Cohort Study	8
	8
The kinesin light chain‐2, a target of mRNA stabilizing protein HuR, inhibits p53 protein phosphorylation to promote radioresistance in NSCLC	8
Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report	8
	8
	8
	8
Early patient‐reported outcomes after robotic‐assisted versus video‐assisted thoracoscopic lobectomy	8
Survival Outcome of Thoraco‐Laparoscopic McKeown Esophagectomy Versus Endoscopic Submucosal Dissection for Early‐Stage Esophageal Squamous Cell Carcinoma: A Propensity Score‐Matched Analysi	8
Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study	8
Abemacilib‐Related Radiation Recall Dermatitis Post Breast Reconstruction: A Case Report and Literature Review	8
Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma	8
Addition of metformin to non‐small‐cell lung cancer patients with or without diabetes	8
Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non‐small cell lung cancers?	8
	8
A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (st	8
Coronavirus disease 2019 (COVID‐19) in patients before, during, or after lung irradiation, and serum SP‐A and SP‐D levels	8
	8
	8
Long‐term stability of pleural fluid carcinoembryonic antigen and its effect on the diagnostic accuracy for malignant pleural effusion	8
Issue Information	8
Hypoxia differently regulates the proportion of ALDHhi cells in lung squamous carcinoma H520 and adenocarcinoma A549 cells via the Wnt/β‐catenin pathway	8
Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: A	8
Exosome‐delivered circSATB2 targets the miR‐330‐5p/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells	8
Prophylactic cranial irradiation in patients with resected small‐cell lung cancer: A systematic review and meta‐analysis	8
Comparing Needle and Surgical Biopsy in Small Peripheral Non‐Small Cell Lung Cancer With Suspected Pleural Invasion: A Propensity Score‐Matched Study	8
Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer	8
Therapeutic Effect of Lymph Node Dissection After Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy on Esophageal Squamous Cell Carcinoma Using the Efficacy Index	8
	8
Adiponectin‐expressing Treg‐containing T cell fraction inhibits tumor growth in orthotopically implanted triple‐negative breast cancer	7
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge	7
Issue Information	7
Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer	7
Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features	7
A Case of Non‐Small‐Cell Lung Cancer With Massive Malignant Ascites Treated With Chemotherapy Combined With Cell‐Free and Concentrated Ascites Reinfusion Therapy	7
Continuous Intraoperative Recurrent Laryngeal Nerve Monitoring in Transcervical Inflatable Mediastinoscopic Esophagectomy	7
Propofol mediates non‐small cell lung cancer growth in part by regulating circ_0003028‐related mechanisms	7
Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma	7
One‐way endobronchial valves in the management of complex persistent air leaks in a soft tissue sarcoma patient	7
Observed and relative survival trends of lung cancer: A systematic review of population‐based cancer registration data	7
Lung Adenocarcinoma With Initially Co‐Occurring EGFR and BRAF Double Mutation: A Case Report and Literature Review	7
Delayed Tumor Shrinkage Beyond Progressive Disease in Small‐Cell Lung Cancer Receiving Immunochemotherapy: A Case Report	7
2‐methoxyestradiol restrains non‐small cell lung cancer tumorigenesis through regulating circ_0010235/miR‐34a‐5p/NFAT5 axis	7
Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non‐small‐cell lung cancer	7
Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study	7
LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis	7
Suitability of Frozen Pleural Fluid Pellets for Next‐Generation Sequencing‐Based Driver Gene Testing in Non‐Small Cell Lung Cancer	7
The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy	7
Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma	7
Gene‐level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay	7
AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines	7
A case of multiple primary lung adenocarcinoma with a CD74‐NRG1 fusion protein and HER2 mutation benefit from combined target therapy	7
Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p‐EGFR and p‐ERK	7
Regulation of ferroptosis‐related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer	7
CircSEPT9 promotes breast cancer progression by regulating PTBP3 expression via sponging miR‐625‐5p	7
Correlations between class I glucose transporter expression patterns and clinical outcomes in non‐small cell lung cancer	7
Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?	7
circ‐TTC17 Promotes Esophagus Squamous Cell Carcinoma Cell Growth, Metastasis, and Inhibits Autophagy‐Mediated Radiosensitivity Through miR‐145‐5p/SIRT1 Axis	7